Australia markets close in 5 hours 17 minutes

Bio-Gene Technology Limited (BGT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.07500.0000 (0.00%)
As of 04:10PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 15.10M
Enterprise value 11.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.09
Enterprise value/revenue 19.96
Enterprise value/EBITDA -4.34

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3-21.88%
S&P500 52-week change 322.64%
52-week high 30.1300
52-week low 30.0380
50-day moving average 30.0613
200-day moving average 30.0685

Share statistics

Avg vol (3-month) 3101.97k
Avg vol (10-day) 381.51k
Shares outstanding 5201.36M
Implied shares outstanding 6201.36M
Float 8100.99M
% held by insiders 144.07%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-8,295.98%

Management effectiveness

Return on assets (ttm)-35.65%
Return on equity (ttm)-65.75%

Income statement

Revenue (ttm)167.99k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-5.30%
Gross profit (ttm)N/A
EBITDA -2.68M
Net income avi to common (ttm)-2.63M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.23M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.08
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-2.94M
Levered free cash flow (ttm)-2.06M